The Hematologic Malignancies Testing market forecasts included in the report are performed by our team of experts and are of great significance as they provide deep insights into various crucial industry parameters. These facts and figures help readers evaluate the global market growth, production, and consumption rates, volatility in demand and product prices, and upcoming market trends over the projected period
According to the current analysis by Emergen Research, the Global Hematologic Malignancies Testing Market size is expected to reach USD 5.45 Billion in terms of revenue from USD 1.95 Billion in 2019, delivering a CAGR of 14.6% through 2027.
To get leading market solutions, visit the link below:
A SWOT analysis is performed on the leading companies engaged in the Hematologic Malignancies Testing market to offer a better understanding of the strengths, opportunities, weaknesses, and threats of the leading companies. It also covers production and consumption rate, the volatility of prices and demands, market share, market size, global position, and market position of each player
Key players in the global hematologic malignancies testing market are ArcherDx, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Invitae Corporation, Abbott Laboratories, NeoGenomics Laboratories, Inc., Cancer Genetics Inc., Asuragen, Inc., Invivoscribe, Inc., and Adaptive Biotechnologies Corporation, among others.
Key Highlights From Report
In March 2020, Sysmex Corporation, a leading diagnostic solutions company, received Japan marketing clearance for the world's largest genome research organization, BGI Group’s coronavirus kit distribution. This initiative strengthened the company’s position in Japan.
Emergen Research has segmented the Global Hematologic Malignancies Testing Market on the basis of product, technology, disease, end-use, and region:
Regional Outlook (Revenue, USD Billion; 2017-2027)
Rest of Europe
Rest of APAC
Rest of LATAM
Middle East & Africa
Rest of MEA
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkdIn | Twitter | Blogs